A new biotechnology startup is aiming to develop genetically enhanced dogs for military use, seeking to improve attributes such as speed, olfactory capabilities, and resistance to hereditary conditions. The venture, named Warhound, was co-founded by Palmer Luckey, known for his role at defense technology company Anduril Industries, and Ben Lamm, co-founder of Colossal Biosciences, a firm focused on de-extinction and conservation efforts.
Warhound, which recently secured $200 million in its initial funding round, counts investors including In-Q-Tel, the venture capital arm linked to the U.S. Central Intelligence Agency, and Sequoia Capital among its backers. Shaun Maguire, a Sequoia partner actively advising the Pentagon, is leading the investment on behalf of the venture firm. The infusion values Warhound at approximately $1.2 billion, according to financial data provider PitchBook.
Headquartered in Texas, Warhound plans to obtain and cryogenically preserve cells from high-performing military and law enforcement dogs with the objective of cloning and genetically modifying them. The company seeks to remove deleterious alleles, or gene variants linked to ailments such as hip dysplasia, while enhancing traits like scent detection, speed, and agility through genetic engineering. In conjunction with these biological improvements, Anduril is set to supply advanced protective gear including specialized eye and hearing protection and body armor designed specifically for the canine units.
Warhound also hopes to reduce reliance on foreign sources for military working dogs, pointing out that nearly 90% of such dogs currently are procured internationally. "We have to do something to onshore what really is a living supply chain," stated David Spirk, Warhound’s chief executive.
Military working dogs play significant roles in U.S. defense operations, including explosive detection, security patrols, narcotics interdiction, and search and rescue missions. The Pentagon currently employs more than 2,200 working dog teams spread across 182 locations worldwide. The U.S. Air Force, responsible for training military working dogs for all branches of the armed forces as well as the Transportation Security Administration, declined to comment on Warhound’s initiative.
The company is initially focusing on Belgian Malinois and German Shepherds, breeds commonly used by military and law enforcement agencies, but intends to include Labradors and additional breeds. Warhound anticipates the birth of its first genetically engineered puppies by early 2027. The dogs are expected to be equipped with advanced sensing technologies integrated by Anduril, whose own AI-powered helmet for soldiers is undergoing early prototype testing.
Colossal Biosciences, which holds an ownership stake in Warhound and has Lamm serving on its board, has garnered attention for its efforts to resurrect extinct species such as the woolly mammoth and dodo. However, some scientists have criticized Colossal’s optimistic scientific claims and cautioned that introducing extensively modified organisms could pose ecological risks. Despite these concerns, Lamm remains confident that breakthroughs in artificial intelligence, quantum computing, and biotechnology will enable the creation of novel life forms in the future.